K F Browne

Author PubWeight™ 32.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993 6.52
2 Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol 1999 2.23
3 Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982 1.45
4 Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn 1996 1.43
5 Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 1995 1.40
6 Worse six-month outcome for patients with multiple stents in a single coronary artery. J Invasive Cardiol 1999 1.39
7 Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control 1984 1.33
8 Prolongation of the Q-T interval in man during sleep. Am J Cardiol 1983 1.25
9 Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol 1997 1.11
10 Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol 1999 1.05
11 Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982 1.01
12 Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995 0.94
13 Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation 1996 0.93
14 Coronary artery perforation repair using microcoil embolization. Cathet Cardiovasc Diagn 1998 0.88
15 Adverse reactions of low osmolality contrast media during cardiac angiography: a prospective randomized multicenter study. J Am Coll Cardiol 1992 0.84
16 Modulation of the Q-T interval by the autonomic nervous system. Pacing Clin Electrophysiol 1983 0.84
17 Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 1996 0.84
18 Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase. J Am Coll Cardiol 1988 0.81
19 Functional bundle branch block: discordant response of right and left bundle branches to changes in heart rate. Am J Cardiol 1984 0.81
20 Intracardiac recording by catheter electrode of accessory pathway depolarization. J Am Coll Cardiol 1983 0.80
21 Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996 0.78
22 Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia. J Am Coll Cardiol 1985 0.78
23 Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators. Circulation 1991 0.78
24 Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol 1995 0.77
25 Additional observations on transvenous cardioversion of recurrent ventricular tachycardia. Am Heart J 1982 0.76
26 Potentially lethal arrhythmias and driving. Ann Intern Med 1992 0.75
27 Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators. J Am Coll Cardiol 1992 0.75
28 Acute reocclusion during percutaneous transluminal coronary angioplasty: immediate and long-term outcome. Cathet Cardiovasc Diagn 1989 0.75
29 Sitting up post angioplasty: a new sheath technology. Cathet Cardiovasc Diagn 1992 0.75
30 Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias. J Am Coll Cardiol 1984 0.75
31 Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug. Am Heart J 1984 0.75
32 Five-hour balloon inflation to resolve recurrent reocclusion during coronary angioplasty. Cathet Cardiovasc Diagn 1991 0.75
33 Intra-aortic balloon counterpulsation in an experimental model of myocardial infarction. Chest 1983 0.75
34 Interventional cardiology techniques for coronary artery disease. J Card Surg 1991 0.75
35 Peripartum bacteremia with CDC group HB-5 (Pasteurella bettyae). Clin Infect Dis 1996 0.75